A Study of ZL-1211 in Patients With Advanced Solid Tumor
Public ClinicalTrials.gov record NCT05065710. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, First-in-Human, Open-Label, Dose Escalation Study of ZL- 1211 in Patients With Unresectable or Metastatic Solid Tumor
Study identification
- NCT ID
- NCT05065710
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Zai Biopharmaceutical (Suzhou) Co., Ltd.
- Industry
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- ZL-1211 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 18, 2022
- Primary completion
- Mar 8, 2024
- Completion
- Apr 8, 2024
- Last update posted
- Sep 2, 2024
2022 – 2024
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Zai Lab Site 2012 | Scottsdale | Arizona | 85258 | — |
| Zai Lab Site 2016 | Lynwood | California | 90262 | — |
| Zai Lab Site 2014 | Indianapolis | Indiana | 46250 | — |
| Zai Site 2020 | Hackensack | New Jersey | 07601 | — |
| Zai Lab Site 2025 | New York | New York | 10016 | — |
| Zai Lab Site 2015 | Cincinnati | Ohio | 45219 | — |
| Zai Lab Site 2011 | Nashville | Tennessee | 37203 | — |
| Zai Lab Site 2023 | Fairfax | Virginia | 22031 | — |
| Zai Lab Site 2013 | Spokane | Washington | 99208 | — |
| Zai Lab Site 2022 | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05065710, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2024 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05065710 live on ClinicalTrials.gov.